Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vito Quaranta

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Nature Reviews. Cancer|June 9, 2019
Author Correction: Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model dataCharles M Rudin, John T Poirier, Lauren Averett Byers, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 11, 2021
Beyond Programmed Death-Ligand 1: B7-H6 Emerges as a Potential Immunotherapy Target in SCLCPortia L Thomas, Sarah M Groves, Yun-Kai Zhang, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancerBenjamin B Morris, Simon Heeke, Yuanxin Xi, et al.
Molecular Cancer|March 21, 2025
DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancerBenjamin B Morris, Simon Heeke, Yuanxin Xi, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
YAP1 defines an emergent, plastic population of relapsed small cell lung cancerC Allison Stewart, Kavya Ramkumar, Runsheng Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 22, 2026
YAP1 defines an emergent, plastic population of relapsed small cell lung cancerC Allison Stewart, Kavya Ramkumar, Runsheng Wang, et al.
Cell Systems|August 18, 2022
Archetype tasks link intratumoral heterogeneity to plasticity and cancer hallmarks in small cell lung cancerSarah M Groves, Geena V Ildefonso, Caitlin O McAtee, et al.
Cancer Cell|January 22, 2021
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCarl M Gay, C Allison Stewart, Elizabeth M Park, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|June 28, 2005
A simplified laminin nomenclatureMonique Aumailley, Leena Bruckner-Tuderman, William G Carter, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2020
New Approaches to SCLC Therapy: From the Laboratory to the ClinicJohn T Poirier, Julie George, Taofeek K Owonikoko, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Nature Reviews. Cancer|June 9, 2019
Author Correction: Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model dataCharles M Rudin, John T Poirier, Lauren Averett Byers, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 11, 2021
Beyond Programmed Death-Ligand 1: B7-H6 Emerges as a Potential Immunotherapy Target in SCLCPortia L Thomas, Sarah M Groves, Yun-Kai Zhang, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancerBenjamin B Morris, Simon Heeke, Yuanxin Xi, et al.
Molecular Cancer|March 21, 2025
DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancerBenjamin B Morris, Simon Heeke, Yuanxin Xi, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
YAP1 defines an emergent, plastic population of relapsed small cell lung cancerC Allison Stewart, Kavya Ramkumar, Runsheng Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 22, 2026
YAP1 defines an emergent, plastic population of relapsed small cell lung cancerC Allison Stewart, Kavya Ramkumar, Runsheng Wang, et al.
Cell Systems|August 18, 2022
Archetype tasks link intratumoral heterogeneity to plasticity and cancer hallmarks in small cell lung cancerSarah M Groves, Geena V Ildefonso, Caitlin O McAtee, et al.
Cancer Cell|January 22, 2021
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCarl M Gay, C Allison Stewart, Elizabeth M Park, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|June 28, 2005
A simplified laminin nomenclatureMonique Aumailley, Leena Bruckner-Tuderman, William G Carter, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2020
New Approaches to SCLC Therapy: From the Laboratory to the ClinicJohn T Poirier, Julie George, Taofeek K Owonikoko, et al.
Pageof 12